Brief: Scholar Rock Says FDA Determined Catalent Indiana Inspection Classification As OAI
Oct 13 (Reuters) - Scholar Rock Holding Corp SRRK.O: SCHOLAR ROCK - NOVO NORDISK INFORMED, FOLLOWING FDA FORM 483 ISSUED TO CATALENT INDIANA, FDA DETERMINED INSPECTION CLASSIFICATION OF FACILITY IS OAI SCHOLAR ROCK- CONTINUE TO WORK CLOSELY WITH NOVO NORDISK, HAVE REQUESTED TYPE A MEETING WITH FDA TO DISCUSS NEXT STEPS FOR RESUBMITTING BLA Further company coverage: SRRK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scholar Rock Holding
See all newsBrief: Scholar Rock Reports New Employee Inducement Grants
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) To European Medicines Agency (EMA) For Treatment Of Children And Adults With Spinal Muscular Atrophy (SMA)
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up